New Zealand shares fell as A2 Milk and Synlait Milk, the best-performing companies on the benchmark index this year, extended their decline amid speculation investors who enjoyed the run-up are now booking profits.
Fisher & Paykel Healthcare rose as the kiwi dollar headed into its third week below US70c.
The S&P/NZX 50 Index declined 3.96 points, or 0.1 per cent, to 8049.67. Within the index, 29 stocks fell, 14 rose, and seven were unchanged. Turnover was $145 million.
The benchmark index has retreated from the record high it reached on October 31 and is now about 1.5 per cent below its peak. Grant Williamson, a director at Hamilton Hindin Greene, said there's "a little bit of nervousness in the market" pending more detail of the new government's policies.
Retirement village operators "were under a bit of pressure" because of the government's intention to lift the minimum wage and cool the property market, he said. Metlifecare fell 0.5 per cent to $5.64, Summerset Group fell 1.5 per cent to $4.67 and Ryman Healthcare, which reports its first-half results on November 23, slipped 0.3 per cent to $9.20.